Visaptverošs pārskats par Vācijas veselības aprūpes sistēmu

This chapter explains how the German healthcare system is actually built: who decides what your insurance pays for, where your contributions go after they leave your payslip, why a specialist appointment is easy to get in one town and impossible in another, and what you can do when your Krankenkasse, your statutory health fund, says no. It is not a guide to seeing a doctor. That is a separate job and the chapter on the German healthcare system in practice does it properly, from finding a Hausarzt to knowing which emergency number to call. This chapter is about the machine behind that experience, because almost everything that frustrates foreigners here is a consequence of the structure rather than of bad luck.

The reason this matters is simple. When something goes wrong in the German healthcare system, newcomers reach for the instinct they brought with them: complain to the government, write to the health ministry, ask the state to fix it. In Germany that instinct fails, and it fails for a reason that is written into the law. The state sets the legal frame and then hands the running of healthcare to a set of self-governing bodies that most residents have never heard of. Once you know their names, the system stops looking arbitrary and starts looking like something you can act on. Nothing here is medical advice, and none of it is legal advice: it is an explanation of how the structure works and where your rights sit inside it.

Selbstverwaltung: Why Nobody Runs the German Healthcare System

The single most important word in this chapter is Selbstverwaltung, which translates as self-administration or self-governance. It means that the German state writes the law but does not deliver healthcare, does not employ the doctors, does not own most of the hospitals and does not decide which treatments are paid for. Instead, the law creates bodies made up of the affected parties themselves, gives them the status of Körperschaften des öffentlichen Rechts, corporations under public law, and delegates real legal power to them. They make binding rules. The ministry mostly watches.

This is not a quirk. It is the organising principle of German social insurance generally, and it is why the five branches of social insurance are described the way they are in the chapter on the sociālā nodrošinājuma sistēmas pārskats. The logic is that the people who pay the contributions and the people who provide the services should negotiate the details between themselves, under legal supervision, rather than have a minister decide by decree. The upside is a system that is technically expert, stable across changes of government, and remarkably hard for any single politician to wreck. The downside is that it is opaque, slow, and accountable to almost nobody the ordinary voter can identify.

For you as a foreigner, the practical consequence arrives the first time you have a real problem. There is no central helpline for the German healthcare system. The Bundesministerium für Gesundheit, the federal health ministry, will not intervene in your case, because your case is not theirs to decide. The bodies described in the next sections are the ones with the power, and each of them has a specific and narrow remit. Knowing which one owns your problem is most of the work of solving it.

The G-BA: the Committee That Decides What You Get

The Gemeinsamer Bundesausschuss, the Federal Joint Committee, usually shortened to G-BA, is the body that decides what the statutory health insurance pays for. If a treatment, a screening, a medicine or a therapy is covered for roughly 74 million insured people, it is generally because the G-BA said so. Its legal basis sits in §91 and §92 SGB V, the fifth book of the German social code, and the instruments it issues are called Richtlinien, directives. They are binding on the Krankenkassen, on doctors in private practice and on hospitals alike. In legal effect they function as subordinate law, not as recommendations.

Its composition is worth reading slowly, because it explains a great deal. The decision-making plenum has thirteen voting members. Three are unparteiische Mitglieder, impartial members, including the chair. Five are named by the GKV-Spitzenverband, the umbrella association of the statutory health funds, which is to say the payer side. Five come from the provider side: two from the Kassenärztliche Bundesvereinigung (KBV), the federal association of panel doctors, two from the Deutsche Krankenhausgesellschaft (DKG), the German hospital federation, and one from the Kassenzahnärztliche Bundesvereinigung (KZBV), its dental equivalent. Patient organisations send up to five representatives who have full rights to take part in the deliberations and to table motions, and no right to vote.

Read that again, because it is the part Anglo readers find hardest to believe. The body that decides what German healthcare covers is not elected by the public, contains no member appointed by parliament, and gives patients a voice but not a vote. It is a corporatist arrangement in the literal sense: the organised interests bargain, and the impartial members hold the balance. The Bundesministerium für Gesundheit has Rechtsaufsicht, legal supervision, which means it can check whether the G-BA stayed inside the law. It cannot substitute its own judgement on the medicine.

None of this is hidden. The G-BA publishes its decisions, meets in public session and documents its reasoning at length on its website. But it is also the answer to a question foreigners ask constantly, which is why some treatment that was routine at home is simply not available on your insurance here, or is available only under conditions that look strange. The answer is usually not that your Krankenkasse is being difficult. The answer is that a committee in Berlin decided, in a published directive, and your Krankenkasse has no power to depart from it.

The Kassenärztliche Vereinigungen and the Sicherstellungsauftrag

The second body you need by name is the Kassenärztliche Vereinigung, the regional association of panel doctors, abbreviated KV. There is one in each federal state. Doctors who treat statutory patients in private practice are not employed by anyone and do not bill your Krankenkasse directly. They are members of their KV, and it is the KV that carries what the law calls the Sicherstellungsauftrag: the legal duty to ensure that outpatient care actually exists and is available to insured people, including at night, at weekends and on public holidays.

The money flows through the same channel. The Krankenkassen do not pay each doctor. They pay a total sum to the KV under a collective contract, and the KV then distributes that pot among its member doctors according to its own distribution rules. This is why the amount a practice earns for treating you is only loosely connected to what your Kasse paid, and why doctors talk about budgets and quarters in a way that makes no sense to a patient from a fee-for-service country. It also explains a common experience: a practice that says it cannot see you until next quarter is not necessarily inventing an excuse.

The Sicherstellungsauftrag is also the most useful thing in this section, because it is a duty owed to you. When the system provides an out-of-hours service, an appointment booking service or a legal maximum waiting time, the KV is the body that owes it. The chapter on accessing medical care in Germany and the practical healthcare chapter both cover how to use those services. What matters structurally is that the obligation has an owner, it is regional, and it is not the ministry.

The Vote You Did Not Know You Had: the Sozialwahl

Self-administration implies that somebody administers, and this is where the German healthcare system does something genuinely unusual that almost no foreigner takes advantage of. The Krankenkassen are governed by a Verwaltungsrat, an administrative council, which is elected. The election is called the Sozialwahl, the social insurance election, and it is held every six years. The last one took place in 2023 and the next is due in 2029. Around 52 million people were entitled to vote in 2023, and turnout was roughly 30 percent.

Here is the part that matters specifically to you: your nationality is irrelevant. Voting rights in the Sozialwahl follow insurance status, not citizenship. If you are insured and old enough, you may vote, whether you hold a German passport or not, and even if you have moved to another EU or EEA state or Switzerland. For a large part of this audience that is remarkable. Many foreigners in Germany pay into the system for years, cannot vote in a Bundestag election, and conclude they have no formal say in anything. In the healthcare system that conclusion is wrong. The ballot arrives by post, most people bin it, and the one election a non-citizen can actually vote in is the one nobody tells them about.

The Verwaltungsrat is not decorative. It adopts the Kasse’s budget. It decides the Satzungsleistungen, the extra benefits a fund writes into its own statutes on top of the legally fixed catalogue. And, in a detail that connects directly to the end of this chapter, it staffs the Widerspruchsausschüsse, the objection committees that rule on appeals against the Kasse’s own decisions. The body that decides whether your appeal succeeds is appointed by an election you were entitled to vote in.

Where Your Money Goes in the German Healthcare System: the Gesundheitsfonds

Follow a euro of your contribution and the structure becomes clearer. Your health insurance contribution does not go to your Krankenkasse. It goes to the Gesundheitsfonds, the central health fund, a single national pool that collects the health contributions of all statutory members together with a subsidy from federal taxes. Your Kasse then receives money back out of that pool. It does not keep what you paid, and what it receives has very little to do with what you personally contributed.

This is the deliberate result of a design choice. If each Kasse simply kept its own members’ contributions, the winning strategy would be obvious and ugly: recruit young, healthy, well paid members and quietly discourage everybody else. Pooling the money centrally and paying it out on a different basis removes the prize. The rates themselves and how they are split with your employer belong to the sociālā nodrošinājuma sistēmas pārskats, which carries the current figures; what concerns us here is the route the money takes and what it does to the incentives.

The federal subsidy in the pool is worth noting too, because it is the seam where healthcare finance meets ordinary politics. The Gesundheitsfonds is not funded by contributions alone, and the size of the tax subsidy is decided in the federal budget, by parliament, not by any self-governing body. That is one of the few levers the state genuinely holds, and as the section on the 2026 reform shows, it is the lever politicians reach for.

The Morbi-RSA and Why Your Kasse Cares Whether You Are Ill

The mechanism that decides how much each Kasse gets back from the pool is the morbiditätsorientierter Risikostrukturausgleich, the morbidity-based risk structure compensation scheme, mercifully abbreviated to Morbi-RSA. The plain version: a Kasse receives an allocation for each insured person, adjusted for how expensive that person is likely to be. Age, sex and documented illnesses feed the calculation. A Kasse with many chronically ill members receives more per head than a Kasse full of healthy thirty-year-olds.

The scheme has been developing for years. Risk adjustment on a simple basis dates back to the 1990s; morbidity was added in 2009; and since 2021 the scheme has run as a Vollmodell, a full model, in which all illnesses feed the calculation rather than a selected list of expensive ones. Alongside it sits a Risikopool for genuinely catastrophic individual cases, introduced with effect from 2021 by the GKV-FKG, the law on fair competition among the funds, which shares the cost of cases above a high annual threshold set at 100,000 euros when it began and raised each year since.

The consequence for you is the thing to hold on to. Because of the Morbi-RSA, a German Krankenkasse has no financial reason to want rid of you when you get sick, and no reason to prefer you when you are healthy. It cannot refuse you, it cannot price you individually, and if you develop an expensive condition its allocation rises to match. This is the structural fact behind an experience that surprises people arriving from insurance markets where illness makes you a bad customer. The solidarity is not primarily a matter of goodwill. It is engineered into the payment formula.

The Zusatzbeitrag and Why Krankenkassen Differ At All

If benefits are set by the G-BA, prices are negotiated collectively and the money is redistributed centrally, an obvious question follows: what is left for the funds to compete on, and why does the choice of Krankenkasse matter at all? The honest answer is that it matters much less than the marketing suggests, and the part that does matter is mostly price.

Each Kasse levies a Zusatzbeitrag, an additional contribution expressed as a percentage of your income, on top of the uniform general rate. This is the fund’s own decision and it is where the competition sits. If a Kasse manages its finances badly, or serves an expensive membership that the Morbi-RSA does not fully compensate, it must raise its Zusatzbeitrag, and members can leave. The average Zusatzbeitrag rose to 2.9 percent on 1 January 2026, up from 2.5 percent in 2025, which is a large jump by the standards of this system and is the direct cause of the political crisis described further down.

Because the rate is a percentage of income rather than a flat fee, the gap between an expensive and a cheap fund is real money on a normal salary, for medical care that is essentially identical. Beyond price, funds differ in their Satzungsleistungen, the statutory extras the Verwaltungsrat votes through, such as larger subsidies for professional teeth cleaning, osteopathy, travel vaccinations or health courses. They also differ in the thing that matters most to a newcomer and appears in no comparison table: whether anyone answers the phone in English, and whether the app works. The chapter on insurance essentials in Germany carries the current thresholds, the number of funds and the rules on switching, and the chapter on public vs private health insurance deals with the GKV and PKV decision itself.

Bedarfsplanung: Why There Is No Doctor Where You Live

Now to the structural fact that generates more foreigner complaints than any other. In Germany, a doctor cannot simply open a practice serving statutory patients wherever they like. The number of panel doctors permitted in a given area, for each specialty, is planned. The rules sit in §§99 to 105 SGB V and the detail is set out in a G-BA directive. The system is called Bedarfsplanung, needs-based planning, and it is the reason your town has four dermatologists and no psychotherapist.

The mechanics are arithmetic. For each planning district and each specialty, a Verhältniszahl is fixed: a ratio of residents per doctor. Compare the doctors actually present against that ratio and you get a Versorgungsgrad, a supply level, expressed as a percentage. Once a district reaches a supply level of around 110 percent for a specialty, it is treated as overserved and closed to new admissions. In a closed district, no new panel practice may open in that specialty, no matter how long the waiting lists are or how obviously the ratio fails to describe reality.

The knock-on effect is that a Zulassung, the admission to treat statutory patients, becomes a scarce and tradeable asset. When a doctor in a closed district retires, the practice does not vanish; a Nachbesetzungsverfahren, a succession procedure, is run by the admissions committee, and a successor takes over the seat. Practices in closed districts therefore change hands for money, and a young doctor who wants to work in a desirable city may have to buy their way in. Meanwhile a rural district that is genuinely underserved struggles to attract anyone, because the planning ratio permits a practice there but nothing compels a doctor to want one.

Two things follow for you. First, when you cannot get an appointment with a specialist, the constraint is often legal rather than commercial: the supply is capped. Second, the ratios are national averages applied to districts whose real needs differ wildly, which is why a wealthy urban district can be formally overserved and still leave you waiting months, while the same specialty is unreachable in the countryside. The system is planning capacity, not demand. Nobody is refusing to build the practice you need; the plan simply says it does not exist.

Sektorentrennung: the Fault Line Under the German Healthcare System

The deepest structural problem in the German healthcare system has a name that never appears in patient-facing material: Sektorentrennung, the separation of sectors. Outpatient care, ambulante Versorgung, and inpatient care, stationäre Versorgung, are not two ends of one system. They are two systems. They have separate money, separate planning, separate rules and separate politics. Doctors in private practice are planned by the KVen under Bedarfsplanung and paid out of the collective pot. Hospitals are planned by the federal states, financed through a mix of state investment money and case-based payments from the funds, and represented by an entirely different organisation.

The border between them is not a clinical line. It is an administrative one, and it produces exactly the pathologies you would expect. The same procedure can be paid for generously on one side and barely at all on the other, so it migrates to the side that pays, not to the side that suits the patient. Information does not cross the boundary well, because the documentation and coding systems on either side were never designed to talk to each other. Capacity sits idle on one side of the line while queues build on the other. Waiting times in Germany are frequently a symptom of this fault line rather than of an absolute shortage.

The current fix is called Ambulantisierung, shifting treatment that no longer needs a hospital bed out of the hospital, and its main instrument is the Hybrid-DRG. Since 2024, a set of selected procedures has been paid at the same flat rate whether performed on an outpatient or an inpatient basis, which removes the financial reason to admit somebody overnight. The KBV puts the effect at roughly 400,000 inpatient cases avoided. It is a genuine structural repair, and it is also a narrow one: it covers a list of procedures, not the boundary itself. The boundary remains, and closing it properly is the unfinished business of German health policy.

The Krankenhausreform and the Leistungsgruppen

The other half of the structural argument is the hospital reform. Germany has an unusually large number of hospitals, many of them small, and a body of evidence that some complex procedures are performed too rarely in too many places to be done well. The Krankenhausversorgungsverbesserungsgesetz, the hospital care improvement act, mercifully abbreviated to KHVVG, took effect on 1 January 2025 and introduced the central instrument: Leistungsgruppen, service groups. A Leistungsgruppe bundles clinically related services and attaches nationwide quality conditions, in staffing and equipment, that a hospital must meet before it may be assigned that group and paid for that work.

The reform has since been reformed. On 6 March 2026 the Bundestag passed the Krankenhausreformanpassungsgesetz, the hospital reform adjustment act, known as the KHAG, which reduced the number of service groups from 65 to 61, deferred the introduction of the Vorhaltevergütung, the payment for simply keeping capacity available, by a year, and gave the federal states more room to manoeuvre. The states may assign a hospital a service group for an initial three years even where it does not yet meet the quality criteria, provided they do so before 31 December 2026. The assignments themselves are due by that same date, so that hospitals get a meaningful preview of the financial consequences for 2027 before the money actually changes.

Read the politics honestly. The quality argument for concentrating complex care in fewer, better equipped hospitals is strong. The countervailing pressure is that closing a hospital, or stripping it of its stroke unit, is locally intolerable, and the states hold the planning pen. The three-year exception for hospitals that miss the criteria is the visible compromise between those two forces. For you as a patient the practical implication is undramatic but real: over the next few years, some treatment will move away from your nearest hospital to a larger one further off, and the reason will be a service group assignment made by your Bundesland.

What the July 2026 Reform Actually Did

The Zusatzbeitrag jump to an average of 2.9 percent made the finances of the statutory system the dominant health story of 2026, and the response was the Gesetz zur Stabilisierung der Beitragssätze in der gesetzlichen Krankenversicherung, the act to stabilise contribution rates, mercifully shortened to GKV-Beitragssatzstabilisierungsgesetz. It passed the Bundestag on 10 July 2026 by 319 votes to 286 with 4 abstentions, and cleared the Bundesrat the same day. It is law. Most of its measures take effect in 2027.

What it does, at system level, is squeeze every part of the machine at once. Co-payments rise by 50 percent, moving the standard range from a minimum of 5 and a maximum of 10 euros to a minimum of 7.50 and a maximum of 15 euros; the draft’s plan to index them annually thereafter was dropped from the final text, so this is a one-off step rather than a permanent escalator. The administrative costs of the Krankenkassen are capped permanently by tying them to the Grundlohnsumme, the wage base. Growth in what providers are paid is limited for 2027 to 2029 to the Grundlohnrate minus one percentage point, which in plain terms means the sector is required to grow more slowly than wages. Pharmaceutical manufacturers face a higher compulsory rebate, raised to 15.5 percent, with a further discount on patented vaccines and a price freeze running to the end of 2030. The federal government’s contribution is to defer the repayment of loans it made to the statutory system in 2023, 2025 and 2026, totalling 5.6 billion euros, and to raise its subsidy in steps from 2027.

It is worth being clear about what that list is. It is not a reform of the structure this chapter has described. It touches neither the Sektorentrennung nor the Bedarfsplanung nor the division of power between the G-BA, the KVen and the funds. It is a cost-containment package: patients pay more per prescription, providers get less growth, manufacturers grant bigger rebates, the funds cut their admin, and the federal government pushes a repayment into the future. The consequence you will actually feel arrives at the pharmacy counter, and the chapter on pharmacies and prescriptions in Germany sets out the co-payment rules in detail, including the annual Belastungsgrenze that caps what you can be charged in total and which this law expressly left alone.

The Primärarztsystem: Announced, Not Law

The reform that would change your daily experience most has not happened. The governing coalition has agreed to introduce a Primärarztsystem, a primary care system, in which a primary care practice becomes the first point of contact and steers access to specialists. A dialogue process with the relevant organisations began in January 2026, the results are being evaluated, and the health ministry has said it intends to bring forward a draft bill. As at July 2026 there is no such law. It is an announced intention at the stage of a ministerial draft, and until a bill has passed the Bundestag and the Bundesrat, nothing about your access to specialists has changed.

This distinction is not pedantry, because a great deal of published advice about Germany, including versions of these very pages, states as fact that you must see your Hausarzt before you may see a specialist. That is wrong today. §76 SGB V grants freie Arztwahl, free choice of doctor: you may go directly to almost any specialist. Only a short list of specialties, seven of them, is genuinely referral-bound, and they are the ones you would never walk into anyway, such as laboratory medicine, pathology and radiology. Gatekeeping exists in Germany only inside the hausarztzentrierte Versorgung under §73b SGB V, a programme you have to opt into voluntarily, usually in exchange for a small bonus from your Kasse. The practical detail of referrals is covered in the chapter on the German healthcare system in practice.

What the Primärarztsystem would do is convert a voluntary arrangement into a general rule, and that is precisely why it is contested. The doctors’ associations, the funds and the patient organisations have very different views about it. Watch for a Referentenentwurf, a ministerial draft bill, then a cabinet decision, then the parliamentary reading. Until that sequence completes, treat any source that tells you Germany has a gatekeeper system as out of date or simply wrong.

When Your Krankenkasse Says No: the Three-Week Rule

Some benefits require the Kasse’s prior approval, and this is where foreigners lose most often, usually by waiting politely. §13 Abs. 3a SGB V contains a rule that very few insured people know. Your Kasse must decide on an application quickly and at the latest within three weeks of receiving it. If it commissions an expert opinion from the Medizinischer Dienst, the medical review service, the deadline is five weeks; in the dental expert procedure under §87 Abs. 1c SGB V it is six. If the Kasse cannot meet the deadline, it must tell you in writing, with reasons, before the deadline expires. If it does not give you a sufficient reason in time, the benefit counts as approved once the deadline passes. That is the Genehmigungsfiktion, the deemed approval.

Now the caveat, and it is a serious one that most guides and a fair number of law firm blogs still get wrong. In a judgment of 26 May 2020 (B 1 KR 9/18 R) the Bundessozialgericht, the Federal Social Court, expressly abandoned its earlier case law on this rule. The deemed approval is no longer treated as a fictitious administrative act, and it does not by itself give you a right to receive the treatment as a benefit in kind. What it gives you is a claim for reimbursement of costs. In practice that means the sequence is: you applied, the Kasse missed its deadline without an adequate written explanation, you then obtained the treatment yourself and paid for it, and you claim the money back. The court also requires that when you self-procured, you did not know, and were not grossly negligent in not knowing, that you had no substantive entitlement, and that the entitlement had not by then been finally decided against you.

So the honest description is narrower than the folklore. The three-week rule is real, it is in force, and it is the strongest lever an insured person has against a slow Kasse. But it is a reimbursement right for people who can front the money, not a magic wand that converts silence into treatment. Note also that it does not cover everything: medical rehabilitation is carved out and runs on its own deadlines under §§14 to 24 SGB IX. The workable use of the rule is to date everything. Apply in writing, keep proof of when it arrived, diarise the three weeks, and if the deadline passes without a properly reasoned letter, say so explicitly in writing. A Kasse that has blown a statutory deadline and knows you know it is a very different correspondent.

Widerspruch and the Sozialgericht: the Appeal Nobody Uses

The ordinary route against a refusal is the Widerspruch, the formal objection. When the Kasse sends you a Bescheid, a formal decision, you have one month from notification to object. If the decision was served on you abroad, the deadline is three months. It does not have to be elaborate: it may be made in writing, electronically, or spoken onto the record at the Kasse itself, and a short letter saying that you object to the decision of a given date, with reasons to follow, stops the clock. Miss the month and the decision becomes final, which is the single most common way people lose cases they would have won.

Your objection does not go back to the person who refused you. It goes to the Widerspruchsausschuss, the objection committee, and here the thread of this chapter ties itself off: that committee is staffed by the Verwaltungsrat, the elected self-administration body from the Sozialwahl section above. This is the Selbstverwaltung acting as a check on its own administration. It is also why a Widerspruch is worth writing rather than treating as a formality. It is not the same people rubber-stamping their own work.

If the committee rejects you, it issues a Widerspruchsbescheid, and from there you may sue at the Sozialgericht, the social court, generally within one month. This is where a genuinely unusual German rule appears, and it is the reason a foreigner should not assume litigation is out of reach. Under §183 SGG, the Social Court Act, proceedings before the social courts are free of court fees for insured persons and benefit recipients bringing or defending a case in that capacity. There is no fee to file. On top of that, §193 Abs. 4 SGG provides that the expenses of the insurance institutions are not reimbursable, which means that if you lose, you are not ordered to pay the Kasse’s legal costs; and the court decides under §193 Abs. 1 whether the parties must reimburse each other, so a claimant who wins is typically awarded their necessary costs against the Kasse.

Be precise about what that does and does not mean. Fee-free does not mean cost-free: if you instruct a lawyer and lose, you pay your own lawyer. But the asymmetric risk that deters litigation in most countries, the fear of being landed with the other side’s costs, is largely absent here. You are not risking your savings to challenge your health insurer. There is legal aid, Prozesskostenhilfe, for those who cannot fund their own representation, and you can bring a case without a lawyer at first instance. For the wider legal landscape, the chapter on medical and health law is the place to look, and the chapter on izdzīvojušā vācu birokrātija covers the general habits, above all the deadlines and the paper trail, that make all of this work.

Tools That Help You See the Money

Very little of this chapter can be automated, because most of it is structure rather than calculation. There are two tools on Werkzeu.ge that fit the money side of it honestly, and it is worth saying plainly that Werkzeu.ge is built by Cryon UG, the company behind WeLiveIn.de.

The Krankenkassen-Wert-Check, a Plus-tier tool, addresses exactly the question this chapter raises in the Zusatzbeitrag section: if the benefits are fixed by law, what is actually different between funds? It scores funds on the Zusatzbeitrag alongside the extras that vary, such as bonus programmes, professional teeth cleaning, osteopathy, travel vaccinations, sports subsidies and Wahltarife, and combines them into a value figure. Its own framing is the honest one, that funds advertise the same core benefits and still differ noticeably in price, extras and service. A comparison tool is only as current as the fund data behind it, so treat the output as a shortlist to verify against the funds themselves rather than as a quotation. The Krankenkassen-Beitragsrechner, also Plus, calculates what a given contribution rate means for your own income, which is the arithmetic that turns an abstract 2.9 percent into a number on your payslip.

Two caveats apply to both, and they are the platform’s own. Werkzeu.ge is in beta until 30 November 2026 and its terms say tools may be incomplete, and it is explicitly not legal, tax or financial advice, which matters here because a Kasse decision is a legal act with deadlines attached. The tools prepare and calculate; they never submit anything to a Kasse or an authority. Both are paid-tier tools, so see the current pricing at werkzeu.ge/en/pricing. Beyond these two there is nothing on the platform that speaks to the G-BA, Bedarfsplanung or an appeal, and it would be dishonest to pretend otherwise.

Ko darīt tālāk

Start with the three names. G-BA decides what is covered. Your KV owes you access to outpatient care in your region. Your Krankenkasse administers your case and can be appealed against. Almost every healthcare problem you will have in Germany belongs to exactly one of those three, and matching the problem to the owner is most of the solution. If you find yourself drafting a complaint to the health ministry, you have almost certainly misidentified the owner.

Then do the two things that cost nothing. Open the envelope when the Sozialwahl ballot arrives in 2029 and vote, because it is very likely the only election you can vote in here and it staffs the committee that will hear your appeal. And adopt the deadline habit now, before you need it: apply in writing, keep proof of the date, count three weeks, and object within one month of any Bescheid you disagree with. Those two habits convert most of the rights in this chapter from theory into something usable.

For the practical layer, read the German healthcare system in practice for the Hausarzt, referrals and emergency numbers, insurance essentials in Germany before you make any decision about which system you are in, pharmacies and prescriptions for what you pay at the counter and how to stop paying once you hit the annual cap, and profilaktiskā veselības aprūpe un labsajūta for the screenings and bonus programmes your contributions already cover. Finally, keep one date in view: the Primärarztsystem is the reform that would change how you reach a specialist, and as at July 2026 it is an announcement, not a law. Check whether a bill has passed before you believe anyone who tells you otherwise.